Investors Menu
Tilray® Announces New Subsidiary Tilray Latin America
Recently acquired subsidiary Alef Biotechnology officially renamed Tilray Latin America NANAIMO, British Columbia --(BUSINESS WIRE)--Dec. 3, 2018-- Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global leader in cannabis research and production, today announced that after completing an acquisition of
December 3, 2018
Tilray, Inc. Reports Third Quarter 2018 Earnings
Revenue rises 85.8% to $10.0 (C$12.9) million in the third quarter and 78.9% to $27.6 (C$35.5) million year-to-date Tilray medical cannabis products available to patients in 12 countries on five continents Signed agreements to supply adult-use cannabis to consumers in eight Canadian provinces and
November 13, 2018
Tilray to Report Third Quarter 2018 Financial Results on November 13, 2018
NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 30, 2018-- Tilray Inc. (Nasdaq: TLRY), a global leader in cannabis production and distribution, announced today it will report results for the third quarter ended September 30, 2018 on Tuesday, November 13, 2018 after market close.
October 30, 2018
High Park Farms™ Receives Cannabis Sales License from Health Canada
TORONTO --(BUSINESS WIRE)--Oct. 1, 2018-- High Park Farms™ Ltd., a subsidiary of Tilray, Inc. (NASDAQ: TLRY), announced today that it has received its sales license from Health Canada to sell cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
October 1, 2018